| 000 | 01743 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515161501.0 | ||
| 264 | 0 | _c20090320 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-08-3131 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaspar, Nathalie | |
| 245 | 0 | 0 |
_aAcquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells. _h[electronic resource] |
| 260 |
_bCancer research _cMar 2009 |
||
| 300 |
_a1966-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xanalysis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzoquinones _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactams, Macrocyclic _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xanalysis |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 | _aTemozolomide |
| 700 | 1 | _aSharp, Swee Y | |
| 700 | 1 | _aPacey, Simon | |
| 700 | 1 | _aJones, Chris | |
| 700 | 1 | _aWalton, Michael | |
| 700 | 1 | _aVassal, Gilles | |
| 700 | 1 | _aEccles, Suzanne | |
| 700 | 1 | _aPearson, Andrew | |
| 700 | 1 | _aWorkman, Paul | |
| 773 | 0 |
_tCancer research _gvol. 69 _gno. 5 _gp. 1966-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-08-3131 _zAvailable from publisher's website |
| 999 |
_c18685796 _d18685796 |
||